Brown Capital Management, an investment management company, released its fourth quarter 2025 investor letter for “The Brown Capital Management Small Company Fund”. A copy of the letter can be ...

Interventional glaucoma treatment with trabecular micro-bypass stent implantation significantly reduces medication burden, which is associated with improved signs and symptoms of ocular surface ...

Adults aged 40 years or older with metabolic syndrome were more likely to have glaucoma than their peers, whereas those with higher BMI or larger waist circumference were less likely to have this eye ...

A new study warns that a widely used eye ointment can damage a popular glaucoma implant. Researchers found that oil-based ointments can be absorbed into the implant’s material, causing it to swell and ...

GLP-1 medications, such as Ozempic and Wegovy, are injected into the fatty layer beneath the skin to manage blood sugar and aid in weight management. The recommended injection sites include the ...

In the last three months, 14 analysts have published ratings on Glaukos (NYSE:GKOS), offering a diverse range of perspectives from bullish to bearish. The table below offers a condensed view of their ...

Shares of Glaukos retreated after the company forecast disappointing sequential revenue growth for its iDose product in the fourth quarter. The stock declined 12% to $97 in after-hours trading on ...

Okay. Thanks, everyone, for joining us today. My name is Allen Gong here on the medical supplies and devices team at JPMorgan. Really glad to be introducing the management team at Glaukos today. We're ...

Research shows that petrolatum-based eye ointments can cause the device to swell and potentially rupture, prompting an urgent update to clinical guidance Widely-used eye ointments can cause glaucoma ...

Widely-used eye ointments can cause glaucoma implants to swell and potentially rupture, according to new research from Nagoya University in Japan. This study is the first to show, using clinical and ...